Israel I. Brekhman

From Wikipedia, the free encyclopedia

Dr. Israel I. Brekhman was a research scientist, in the field of organic medicine and biologically active substances. Professor and Doctor of Medical Sciences, his career focused on unlocking the genetic secrets of plants and herbs and improving health and well-being.

Brekhman1.jpg
Brekhman1.jpg

I. I. Brekhman won a coveted place at the Naval Medical Academy of the U.S.S.R. in Leningrad, specializing in Pharmacology. Upon his graduation as a medical doctor in 1945, he was sent by the Navy to the Far East of Russia, where he spent the rest of his life. During his remarkable 45 years of research, Dr. Brekhman became the world authority on adaptogens. He is best known in the West for his pioneering work on "Siberian" ginseng (Eleutherococcus senticosus).

Much of the scientific literature on Eleutherococus is from Brekhman's articles on this tonic herb. His first article on Eleutherococcus in a scientific journal, "A New Medicinal Plant of the Family of Araliaceae -- The Spiny Eleutherococcus" (1960), had a tremendous impact not only on the scientific community, but also on the general public. Only two years after Brekhman's first published work, the Eleutherococcus extract was approved by the Pharmacological Committee of the U.S.S.R. Ministry of Health for clinical use as a "stimulant."

For his discoveries and work developing natural plant substances, Dr. Brekhman held nearly 40 patents, including 21 international patents. He published 22 monographs and hundreds of scientific articles and books. Many books and journals on adaptogens, published in the United States, Japan, and Sweden, have been based on Dr. Brekhman and his landmark work.

Although relatively unpublished to western civiliztion, Adaptogen research and studies pertaining to them gained great momentum in Russia during the cold war era. During this time Dr. Brekhman pioneered a vast scientific effort funded by the Russian government involving a reported 1200 scientists. This scientific community explored plant biological codes and analyzed their molecular structures. After 45-years of research and thousands of clinical trials, a patented formulation, Prime One was created.

The Soviet Union and The Russian National Parliament bestowed on Brekhman the Order of Lenin, The Lenin Medal for valiant work, as well as the coveted Certificate of Honour, these awards came to him for breaking the genetic codes of plants, uncovering the molecular structures of their phyto-chemicals and his lifetime work with Adaptogens.

As the founder and permanent director of the Committee for the Study of Far East Medicinal Plants, Dr. Brekhman also headed the Department for Regulation of Biological Processes at the Pacific Oceanographic Institute of the Russian Academy of Sciences. He served on the board of the Russian Academy of Technological Sciences and the International Organization of Adaptive Medicine in Frankfurt, Germany, and was an advisor to the Annual Dead Sea Conferences on Well-being.

Dr. Brekhman organized and led three international symposia on adaptogens in Hamburg, Moscow, and Khabarovsk. He also participated in many international congresses and conferences (London, Tokyo, Prague, St. Petersburg). He served on various international committees and was invited to lecture at the Universities of London, Stockholm, Oslo, and Copenhagen.

“It has always been my dream to create a special formula to prepare people for life and to protect them from stress.” Dr Israel I. Brekhman 1921 - 1994

[edit] External links